Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations. [electronic resource]
- Vaccine 08 2019
- 4830-4834 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-2518
10.1016/j.vaccine.2019.06.053 doi
Antibodies, Viral--blood Congresses as Topic Cross Protection Human Experimentation Humans Influenza Vaccines--administration & dosage Influenza, Human--prevention & control Licensure London Pandemics--prevention & control Research Design Vaccination--adverse effects World Health Organization